Transformation of Conventional Publication Models into Digital Scientific Publishing: A Remarkable Paradigm Shift in Publishing Industry

Food and Healthcare Press Releases Tuesday October 10, 2017 20:49
LONDON and SINGAPORE--10 Oct--PRNewswire/InfoQuest
  • OMICS International Open access journals gaining more popularity and Open access week celebrating from October 23-29, 2017

As of October 2017, there are 11,000   Open access journals publishing 2,322,691 articles annually, as per Google Scholar is proof of a revolution in publishing systems from the traditional print based publication. Digital publication systems are providing free access to scientific information on science, technology and medicine and other scientific reports via Internet-enabled technologies.

Online   Open access publications are extending outstanding support towards the overall process of traditional publishing, including editing and reviewing. Technology-enabled Open access publishing systems are able to attract several reputed universities, scientific societies, learned academics, and independent companies to digitize their ways of publication and archiving.

Commenting on the recent developments in the digital publication forum, Dr. Srinubabu Gedela , CEO of OMICS International has mentioned that   Open access scientific publishing is removing language barriers. If scientific research is published in Open access journals, it can be translated to multiple of languages without copyright laws. "The industry is still working on the improvisation to reach even the remotest corners of the globe with cost effective, affordable and free scientific information." Dr. Gedela added, "Fake news and a few fake blogs are affecting the reputation of Open access journals, as these are created by the puppets of pay access publishers."

Now the leading Open access journals have captured momentum. Almost all leading publishers are maintaining or adopting Open access journals policies , which are going to set the direction of future publishing and literature archival. "It's a good sign," Dr. Gedela added. Support from the learned societies towards including academic societies, government bodies all other member of the scientific community is pouring after realizing the far reaching impact of Open access digital publishing.

OMICS International with its 2500+ employees has been a pioneer in the dissemination of scientific and healthcare information and celebrating Open access week. With the help of 50,000+ well-qualified scientists as editorial board members.   OMICS International is able to grow from 10 journals in 2009 to 1000+   peer reviewed journals by 2017 with an increased reader base of 30 million.   OMICS Group is also conducting 3,000+ annual scientific and medical meetings in association with international partners.

Contact: contact.omics@omicsonline.org ; 650-268-9744
Logo - https://mma.prnewswire.com/media/569968/OMICS_INTERNATIONAL_150X30.jpg

Latest Press Release

ESMO Publishes New Position Paper on Supportive and Palliative Care

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer...

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,...

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral...

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Related Topics